Vaccine reported cases from VEARS
Guillain-Barre Syndrome
https://medicaltrend.org/2021/07/25/johnson-johnson-covid-19-vaccine-gbs-risks-and-booster-shots/
| Vaccine Manufacturer | Events Reported | Percent (of 425,950) |
|---|---|---|
| Janssen | 44,001 | 10.33% |
| Moderna | 195,404 | 45.87% |
| Pfizer\Biontech | 199,472 | 46.83% |
| Unknown | 1,008 | 103.27% |
https://wonder.cdc.gov/controller/datarequest/D8;jsessionid=2C9F06F93D3F005DA9337FD49274#Top